NEW YORK--(BUSINESS WIRE)--
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in American Renal Associates Holdings, Inc. (“ARA”) (NYSE:ARA) of the October 31, 2016 deadline to seek the lead plaintiff role in a federal securities class action filed against ARA and certain officers.
The lawsuit, Gelsleichter v. American Renal Associates Holdings, Inc. et al, No. 1:16-cv-06841, was filed on August 31, 2016 in U.S. District Court for the Southern District of New York on behalf of all those who purchased ARA securities: (1) pursuant to ARA’s IPO around April 21, 2016; and/or (2) from April 21, 2016 through August 18, 2016 (“Class Period”).
The lawsuit alleges defendants violated federal securities laws by making misleading statements and/or failing to disclose that ARA engaged in a scheme to steer patients from qualified-for-Medicare-and-Medicaid plans into ACA plans to obtain greater reimbursement for ARA’s services.
Request more information now by clicking here: www.faruqilaw.com/ARA . There is no cost or obligation to you.
Take Action
If you invested in ARA stock/options during the IPO and/or Class Period and would like to discuss your legal rights, visit www.faruqilaw.com/ARA. You can also contact Richard Gonnello via telephone and/or e-mail, listed below.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New
York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone:
(877) 247-4292 or (212) 983-9330
View source version on businesswire.com: http://www.businesswire.com/news/home/20160927006611/en/
